Latest: Clean Science & Technology Ltd Q1 FY27 results →All Q4 FY26 results →
CS

Clean Science & Technology Ltd

Q4 FY26Chemicals & Petrochemicals

Clean Science & Technology Q4 FY26 earnings call: Revenue & Margins

Q4 FY26 earnings call: what management said on revenue, margins and capex.

Price₹826
Market cap₹8.2K Cr
P/E35.1
Updated23 Aug 2026
Read4 min read

The short version

HALS sales have shown strong growth, increasing from ~350-360 tonnes per quarter eight quarters ago to over 1,000 tonnes per quarter currently, with momentum expected to build further. HALS business shows strong momentum with sales increasing from ~350-360 tonnes per quarter (8 quarters ago) to over 1,000 tonnes per quarter currently, with expectations to continue building volumes and improving margins through higher-grade products and backward integration.

From Clean Science & Technology Ltd's Q4 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

  • HALS sales have shown strong growth, increasing from ~350-360 tonnes per quarter eight quarters ago to over 1,000 tonnes per quarter currently, with momentum expected to build further.
  • Higher grades of HALS are contributing to better revenue and margins, indicating improved product mix.
  • Stand-alone business volumes grew sequentially by about 8%, mostly volume-led growth.

2 more points from Clean Science & Technology Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Clean Science & Technology Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • Capex budget for FY27 is expected to be in the range of INR 80 crores to INR 100 crores (Page 16).
  • Backward integration efforts ongoing for HALS intermediates by refurbishing pharma plants, expected to improve margins and reduce import dependence (Page 17).
  • Capex related to water treatment product (Performance 2) is pushed to September, with commercial production expected by FY28 (Page 9).

2 more points from Clean Science & Technology Ltd's call on capex

Create a free account to keep reading this call

Top-ranked in Chemicals & Petrochemicals

Ranked on what management guided this quarter

Guidance-ranked
1Shiv Texchem
Rev 1Mar 2
Rev 1Mar 3
3
Rev 1Mar 3
4
Rev 1Mar 3
5
Rev 2Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Clean Science & Technology Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

From the discussion and responses, the following insights are available: - The company has seen strong momentum building in HALS sales, reaching over 1,000 tonnes per quarter in Q4 FY26. - Volume growth is primarily driven by increased customer offtake and expanding exports. - Sales are largely end-to-end to consumers; contract manufacturing is not a significant part currently. - Distribution tie-ups and direct customer relationships have contributed to order growth.

2 more points from Clean Science & Technology Ltd's call on order book

Create a free account to keep reading this call

Clean Science & Technology Ltd — Quarterly revenue & net profit

Revenue Net profit
Mar 2025Q4 FY25
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27

Reported quarterly figures (₹ Cr). Latest (Q1 FY27): revenue ₹268 Cr, net profit ₹73 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Chemicals & Petrochemicals this season

  • Indian Phosphate Ltd (Q4 FY26)

    H2 FY26 Revenue (Consolidated):** ₹580.25 Cr, up from ₹451.59 Cr in H2 FY25 — a year-on-year increase of ₹128.66 Cr. Key investor presentation takeaways from In

  • Paragon Fine (Q4 FY26)

    Revenue for H2FY26:** Rs 68.88 Cr, up 7.41% YoY from Rs 64.13 Cr in H2FY25 (Page 22). Key investor presentation takeaways from Paragon Fine's Q4 FY26 investor p

  • IVP Ltd (Q4 FY26)

    Q4 FY26 revenue from operations: ₹164.44 crore . Key investor presentation takeaways from IVP's Q4 FY26 investor presentation — and how it ranks against sector

  • Vishnu Chemicals Ltd (Q4 FY26)

    Q4 FY26 Operating Revenues: ₹450.3 crore, up 14.7% YoY from ₹392.6 crore in Q4 FY25 (Page 5). Key investor presentation takeaways from Vishnu Chemicals Ltd's Q4

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Clean Science & Technology Ltd and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Clean Science & Technology Ltd Q4 FY26 results?

HALS sales have shown strong growth, increasing from ~350-360 tonnes per quarter eight quarters ago to over 1,000 tonnes per quarter currently, with momentum expected to build further. HALS business shows strong momentum with sales increasing from ~350-360 tonnes per quarter (8 quarters ago) to over 1,000 tonnes per quarter currently, with expectations to continue building volumes and improving margins through higher-grade products and backward integration.

What is Clean Science & Technology Ltd share price analysis?

Clean Science & Technology Ltd currently shows a neutral. The stock trades at a P/E of 35.1 with a market cap of ₹8,173 Cr. Investors should review the full earnings analysis for detailed insights.

Is Clean Science & Technology Ltd planning capital expenditure?

Capex budget for FY27 is expected to be in the range of INR 80 crores to INR 100 crores (Page 16).

Keep Clean Science & Technology Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.